Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate
Source: scienceblog.com
Page 10 - Evaluate Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evaluate Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evaluate Efficacy Today - Breaking & Trending Today
UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19
The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.
Source: news-medical.net
Essentia Health joins nationwide study to test medications for COVID-19
Study focuses on medicines that are already on the market for other illnesses.
Source: pineandlakes.com
AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization (ECCO)
/PRNewswire/ -- AbbVie (NYSE: ABBV) will present further analyses on HUMIRA® (adalimumab) and the investigational uses of risankizumab (SKYRIZI®) and...
Source: prnewswire.com
Essentia joins nationwide study to test medications for COVID-19 use
Essentia Health serves as a clinical research site supporting ACTIV-6 by referring eligible study participants. It will enroll and monitor patients’ progress throughout the study’s 90-day follow-up period and will assist them with any questions or concerns that arise.
Source: brainerddispatch.com